Related Experiment Video
Updated: Jul 9, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
The VIZIER project: preparedness against pathogenic RNA viruses
B Coutard1, A E Gorbalenya, E J Snijder
1Architecture et Fonction des Macromolécules Biologiques, CNRS, and Universités d'Aix-Marseille I et II, UMR 6098, ESIL Case 925, 13288 Marseille Cedex 09, France.
The VIZIER project aims to prepare for unknown RNA viruses by studying conserved viral replication enzymes. Determining viral replicase crystal structures provides a foundation for rapid antiviral drug development against emerging threats.
Area of Science:
- Virology
- Structural Biology
- Drug Discovery
Background:
- Emerging RNA viruses pose significant public health threats.
- Antiviral drug development is slow, hindering preparedness for novel viral outbreaks.
- A proactive strategy is needed to rapidly respond to new viral threats.
Purpose of the Study:
- To establish scientific foundations for countering emerging RNA viruses.
- To study conserved viral enzymes (replicases) as drug targets.
- To generate critical knowledge for rapid antiviral research.
Main Methods:
- Multidisciplinary approach including bioinformatics, viral genomics, proteomics, and structural biology.
- Determination of viral replicase crystal structures for diverse RNA viruses.
- Pre-lead discovery to identify potential antiviral scaffolds.
Main Results:
- Comprehensive coverage of RNA virus diversity through structural studies.
- Identification of conserved viral replicase structures.
- Generation of knowledge applicable to emerging viral threats.
Conclusions:
- The VIZIER project provides a framework for rapid response to emerging RNA viruses.
- Structural determination of viral replicases is key to accelerating antiviral drug design.
- Proactive research on viral enzymes enhances global health security.
Related Concept Videos
Viruses with RNA Genomes
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors Of Virion Release
Human Virome
Rapid Identification of Pathogens

